ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004

An Appreciation: Janet Rowley, “Translational Research Pioneer”

January 3, 2014

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000